Trial
NCT03414008
This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Healthy
Intervention
BI 1291583
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-13